Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 69,970 shares at $8.94 ($609K) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Open-market sale of $609k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.94 | 15,941 | $143K | 23.4% |
| 2 | $8.94 | 15,941 | $143K | 23.4% |
| 3 | $8.61 | 9,544 | $82K | 13.5% |
| 4 | $8.61 | 9,544 | $82K | 13.5% |
| 5 | $8.39 | 19,000 | $159K | 26.2% |
| Total | $8.70 avg | 69,970 |
| $609K |
| 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |